NVS•benzinga•
Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
Summary
Roche's Xolair outperformed oral immunotherapy in a Phase 3 trial for food allergies, showing better tolerance and fewer adverse events.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga